“Intrauterine Misoprostol Versus Intravenous Oxytocin for the Prevention of Primary Postpartum Hemorrhage During Cesarean Section: A One-Year Randomized Controlled Trial”, Eastern Med. Coll. J., vol. 10, no. 2, pp. 111–115, Jan. 2026, doi: 10.3329/emcj.v10i2.85706.